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Summary
Although the growth capacity of mature neurons is often
limited, some neurons can shift through largely unknown
mechanisms from stable maintenance growth to dynamic,
organizational growth (e.g. to repair injury, or during
development transitions). During insect metamorphosis,
many terminally differentiated larval neurons undergo
extensive remodeling, involving elimination of larval neurites
and outgrowth and elaboration of adult-specific projections.
Here, we show in the fruit fly, Drosophila melanogaster
(Meigen), that a metamorphosis-specific increase in insulin
signaling promotes neuronal growth and axon branching after
prolonged stability during the larval stages. FOXO, a negative
effector in the insulin signaling pathway, blockedmetamorphic
growth of peptidergic neurons that secrete the neuropeptides
CCAP and bursicon. RNA interference and CCAP/bursicon
cell-targeted expression of dominant-negative constructs for
other components of the insulin signaling pathway (InR,
Pi3K92E, Akt1, S6K) also partially suppressed the growth of
the CCAP/bursicon neuron somata and neurite arbor. In
contrast, expression of wild-type or constitutively active forms
of InR, Pi3K92E, Akt1, Rheb, and TOR, as well as RNA
interference for negative regulators of insulin signaling
(PTEN, FOXO), stimulated overgrowth. Interestingly, InR
displayed little effect on larval CCAP/bursicon neuron growth,
in contrast to its strong effects during metamorphosis.
Manipulations of insulin signaling in many other peptidergic
neurons revealed generalized growth stimulation during
metamorphosis, but not during larval development. These
findings reveal a fundamental shift in growth control
mechanisms when mature, differentiated neurons enter a
new phase of organizational growth. Moreover, they highlight
strong evolutionarily conservation of insulin signaling in
neuronal growth regulation.
 2013. Published by The Company of Biologists Ltd. This
is an Open Access article distributed under the terms of
the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution and reproduction in any
medium provided that the original work is properly
attributed.
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Introduction
Although differentiated neurons have relatively stable
morphologies, they nevertheless undergo dynamic structural
changes in order to sustain their functions. These maintenance
growth processes include the recycling of membrane and other
cellular components (Kelly, 1993; Zimmermann et al., 1993), the
expansion or retraction of synaptic contacts (Zito et al., 1999;
Eaton et al., 2002), and growth in proportion to changes in tissue
size (Bentley and Toroian-Raymond, 1981; Loesch et al., 2010).
For example, mouse lumbar spinal motorneurons, D. melanogaster
sensory neurons, and Manduca sexta (tobacco hornworm) larval
motorneurons all display post-embryonic growth in proportion to
body size while maintaining their topologies (Truman and Reiss,
1988; Li et al., 2005; Parrish et al., 2009).
Neurons display another, organizational form of growth
associated with axonal and dendritic pathfinding and
elaboration of new neuronal arbors. Organizational growth is
normally restricted to initial neuronal differentiation, but it also
occurs in fully differentiated neurons under certain situations,
including puberty, insect metamorphosis, and seasonal changes in
bird song control centers, and in response to injury, stroke, or
neurological disease (Levine and Truman, 1982; Finger and
Almli, 1985; Brenowitz, 2004; Blakemore and Choudhury, 2006;
Benowitz and Carmichael, 2010). Mature neurons vary widely in
their capacities to undergo organizational growth (Holm and
Isacson, 1999; Goldberg and Barres, 2000), and the factors
contributing to these differences are poorly understood.
Nevertheless, several known regulators of organizational
growth, such as neurotrophic factors, cell adhesion molecules,
and modulators of cytoskeletal reorganization, are associated
with neurodegenerative diseases (Mattson, 1990; Cotman et al.,
1998; Kao et al., 2010). There is intense interest in finding ways
to stimulate organizational growth in mature neurons to counter
nervous system damage (Maier and Schwab, 2006; Mattson,
2008; Zhang et al., 2008).
Insect neurons are a powerful model for examining transitions
between maintenance and organizational growth and for studying
differences in the control of these distinct growth processes. In
holometabolous insects, fully differentiated larval neurons
exhibit maintenance growth during the larval stages and a
second, post-embryonic phase of organizational growth during
metamorphosis. During this latter phase, many larval neurons are
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retained and undergo significant structural remodeling; larval
axons and dendrites (neurites) are pruned back, and this is
followed by the outgrowth of adult projections (Truman, 1990).
The D. melanogaster CCAP/bursicon neurons provide an
excellent genetic model to examine post-embryonic
organizational growth (Zhao et al., 2008). These neurons
secrete multiple neuropeptides, including bursicon and
crustacean cardioactive peptide (CCAP), to regulate molting
behaviors (Park et al., 2003; Dewey et al., 2004). In larvae, the
CCAP/bursicon neurons consist of at least 3 pairs of neurons in
the brain (with one or both peptides), 3–4 pairs of neurons in the
lateral subesophageal ganglia, and at least 21 pairs in the ventral
nerve cord (VNC) (Hodge et al., 2005; Vo¨mel and Wegener,
2007; Zhao et al., 2008). Most of these neurons project within the
VNC, but several abdominal pairs send efferent projections via
segmental nerves to the periphery to terminate on larval body
wall muscles, where they form neuroendocrine endings (Hodge et
al., 2005; Vo¨mel and Wegener, 2007; Zhao et al., 2008).
Additional efferents terminate in the more posterior abdominal
nerves (this study). The morphology of the CCAP/bursicon
neurons is maintained throughout larval development, but they
grow more than two-fold in size in proportion to the overall larval
growth (supplementary material Fig. S1). During metamorphosis,
the larval axons and dendrites are pruned back almost to the cell
bodies, followed by outgrowth of adult-specific neurites, which
include a peripheral, tree-like axonal arbor with en passant
neuroendocrine boutons (Zhao et al., 2008).
The CCAP/bursicon neurons are essential for completion of
two events in the life cycle: pupal ecdysis, at the onset of
metamorphosis, and wing expansion, which occurs after
metamorphosis is completed and the adult has eclosed
(McNabb et al., 1997; Park et al., 2003). Disruption of the
CCAP/bursicon neurons prior to pupal ecdysis produces animals
that fail to evert the adult head from the thorax and to fully
elongate the adult legs and wings. Later perturbation of the
CCAP/bursicon neurons during metamorphosis leads to viable,
fertile adults with permanently unexpanded wings (Zhao et al.,
2008). Although pupal ecdysis and wing expansion behaviors
each last only a few minutes, the resulting morphological defects
persist for days and are easy to score (Zhao et al., 2008).
Therefore, we can conduct large-scale genetic screens for factors
that contribute specifically to organizational growth by selecting
for genetic alterations in the CCAP/bursicon neurons that
preferentially disrupt wing expansion.
In vertebrates, insulin and insulin-like growth factor 1 (IGF-1)
are both important regulators of nervous system growth and
maturation. IGF-1 has well-established functions in controlling
neuronal growth, survival, and plasticity, and in maintaining
cognitive function throughout the lifespan (Aleman and Torres-
Alema´n, 2009). Insulin, a critical regulator of nutrient
homeostasis, has been implicated more recently in the
morphogenesis and function of the central nervous system
(CNS) (Chiu and Cline, 2010; Huang et al., 2010). Several
neuronal cell culture studies have revealed a role for insulin
receptor signaling in regulating neurite growth (Govind et al.,
2001; Choi et al., 2005), and in vivo studies in retinotectal circuits
of the frog Xenopus laevis have shown that insulin receptor
signaling is required for dendritic arborization (Chiu et al., 2008).
The insulin and insulin-like growth factor signaling (IIS)
pathway has been highly conserved throughout evolution. The
structure of the mature peptide hormones is shared by mollusks,
nematodes, insects, and humans (Conlon, 2001; Claeys et al.,
2002), and these peptides act on a small family of closely related
receptor tyrosine kinases that stimulate a canonical intracellular
signaling pathway (Claeys et al., 2002). In Drosophila, the
insulin-like peptides are encoded by eight genes (dilp1–8) and are
produced in the CNS, gut, imaginal discs, and fat body (Brogiolo
et al., 2001; Colombani et al., 2012; Garelli et al., 2012). Once
secreted, all of the DILPs are thought to bind and activate a single
Drosophila insulin-like receptor (InR) (Brogiolo et al., 2001),
which in turn activates insulin receptor substrate (IRS). IRS
stimulates a series of kinases, including phosphatidylinositol 3-
kinase (PI3K) and Akt/protein kinase B, to regulate metabolism,
cell and tissue growth, longevity, and neuronal properties (Ikeya
et al., 2002; Rulifson et al., 2002; Broughton and Partridge, 2009;
Naganos et al., 2012).
Here, we examined the role of IIS in growth of the CCAP/
bursicon neurons. Our results showed that signaling through InR
strongly regulates the organizational growth of the CCAP/
bursicon neuron cell bodies and neurite arbor during
metamorphosis, but IIS plays only a small role in larval
maintenance growth. We tested whether IIS regulates the
growth of other peptidergic CNS neurons, and in most cases,
the organizational growth seen during metamorphosis was
substantially more sensitive to IIS than larval maintenance
growth. These findings reveal a fundamental shift in growth
control mechanisms as many neurons are remodeled, and they
highlight an important role of IIS in this process.
Materials and Methods
Fly strains, genetic manipulations, and scoring
Fly stocks were cultured on a standard cornmeal–yeast–agar medium, and crosses
were performed at 25 C˚. The following strains were obtained from the
Bloomington Drosophila Stock Center: ccap-Gal4 (y* w*;P{ccap-Gal4.P}16;
FBti0037998); UAS-InR (y1 w1118; P{UAS-InR.Exel}2; FBst0008262); UAS-InRact
(y1 w1118; P{UAS-InR.R418P}2; FBst0008250); UAS-InRDN (y1 w1118; P{UAS-
InR.K1409A}2; FBst0008259); UAS-PI3K (y1 w1118; P{UAS-Pi3K92E.Exel}2;
FBst0008286); UAS-PI3Kact (P{UAS-Pi3K92E.CAAX}1, y1 w1118; FBst0008294);
UAS-PI3KDN (P{UAS-Pi3K92E.A2860C}1, y1 w1118; FBst0008288); UAS-Akt
(P{UAS-Akt1.Exel}1, y1 w1118; FBst0008192); UAS-PTENRNAi (w1118; P{UAS-
Pten.dsRNA.Exel}3; FBst0008550); UAS-Rheb (y1 w*; P{Mae-
UAS.6.11}RhebLA01053/TM3, Sb1 Ser1; FBst0022248); UAS-S6K (w1118; P{UAS-
S6k.M}2/CyO; FBst0006910); CyO, tubPGal80 (w*; l(2)DTS911 nocSco/CyO,
P{tubP-Gal80}OV2; FBst0009491); and Oregon-R (wild type; FBst0004269).
Other RNAi lines were obtained from the Vienna Drosophila RNAi Center. UAS-
foxow+[m3-1] and UAS-foxoTM[f3-9] were kindly provided by Marc Tatar
(Providence, Rhode Island, USA). w; bursicon-Gal4[P12] was made by Willi
Honegger (Nashville, Tennessee, USA) and provided by Ben White (Bethesda,
Maryland, USA). w*, UAS-Dcr-2 was made by Stephan Thor (Linkoping, Sweden)
by mobilizing a UAS-Dcr-2 insertion (FBti0101430) (Dietzl et al., 2007) to a new
X chromosome location to enhance the effect of RNAi, and that line was kindly
provided by Paul Taghert (St Louis, Missouri, USA).
Wing expansion defects were scored as unexpanded wings (UEW), partially
expanded wings (PEW), and expanded wings as described (Luan et al., 2006b).
Immunostaining
Immunostaining was performed on isolated CNS or on whole-animal fillets of
wandering 3rd instar larvae or staged pupae (Bainbridge and Bownes, 1981) as
described (Hewes et al., 2006). Primary antisera were used overnight at 4 C˚ and
were directed against the following proteins: CCAP (1:4000, PFA/PA) (Park et al.,
2003), Bursicon a-subunit (1:5000, PFA/PA) (Luan et al., 2006a), DILP7 (1:1000,
PFA/PA) (Yang et al., 2008), and FOXO (1:1000, PFA) (Puig et al., 2003). The
FOXO antibody was used to confirm overexpression of FOXO in ccap.FOXO
animals (data not shown). All tissues were mounted with Vectashield (Vector
Labs, Burlingame, CA) for observation using an Olympus FluoView FV500
confocal microscope (Center Valley, PA).
Staining quantification
Confocal image quantification was performed as described (Hewes et al., 2006;
Zhao et al., 2008), and the images shown in the figures are representative of the
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mean values. The same confocal scanning settings, which were optimized to avoid
image saturation, were used for all preparations within each experiment. For
quantification of cell soma area, we converted the confocal Z-series stacks to
maximum projection images, manually traced the cell border, and obtained a count
for the bordered pixels in Adobe Photoshop. For quantification of arbor area, we
used the inversion and threshold functions in Adobe Photoshop (with the same
threshold of 235 for all images) to convert the background to white and all
remaining pixels (arbor and somata) to black. The somata and any obvious artifacts
were manually cut from each image, and then we obtained a count of the black
pixels. Although we used the same settings for all images within an experiment,
the intensity of images varied from experiment to experiment, necessitating the use
of different scan settings. Therefore, results from different experiments are not
comparable. To quantify the density of peripheral axon branches within a
standardized field, branches were counted manually within a 785 pixel6415 pixel
window that was centered over the arbor with the top edge aligned with the first
major branch point. To correct for differences in animal size, counts of bouton
numbers at the larval CCAP/bursicon cell NMJs were normalized by the cross-
sectional area measured for muscle 6 in abdominal segment 4. However, the size of
muscle 6 did not vary significantly, and the results would have been the same
without normalization. Statistical tests were performed using NCSS-2001 software
(NCSS, Kaysville, UT) or at http://www.vassarstats.net, and a level of significance
of 0.05 was used for all post-hoc tests performed following ANOVAs. All data are
presented as means 6 s.e.m. The numbers of animals for each genotype are
indicated with each histogram bar in the figures. *P,0.05, **P,0.01,
***P,0.001.
Results
Overexpression of foxo disrupted metamorphic growth of the
CCAP/bursicon neurons
In a previous genetic screen, we found that overexpression of the
foxo transcription factor (forkhead box, sub-group O; FlyBase ID
FBgn0038197) in the CCAP/bursicon neurons disrupted normal
wing expansion (Zhao et al., 2008). Since FOXO is a negative
regulator of IIS (Puig et al., 2003), we first examined the cellular
effects of FOXO overexpression and investigated the timing and
extent of IIS regulation of CCAP/bursicon neuron growth in
larvae and during metamorphosis.
Following single crosses, all flies expressing UAS-foxo under
the control of a ccap-Gal4 driver (ccap.FOXO) had completely
folded wings (n5122). Since the CCAP/bursicon neurons are
essential for initiation of wing expansion behavior (Park et al.,
2003; Dewey et al., 2004), this result suggested that foxo
overexpression disrupts the development, function, or survival of
these neurons. To test this hypothesis, we performed anti-
bursicon immunostaining on stage P14 pharate adult CNS
(Bainbridge and Bownes, 1981) (Fig. 1). We observed a 65%
reduction in the number of bursicon-immunopositive somata
throughout the CNS (Fig. 1A,D), with loss of 71% of the
abdominal bursicon neurons (BAG) (supplementary material Fig.
S2), and the remaining cells displayed abnormal morphology,
with reduced soma sizes and peptide expression, and a near
complete loss of central and peripheral neurites (Fig. 1A9). All of
the BAG also express CCAP (and there are ,14 additional
abdominal neurons that express CCAP only (Luan et al., 2006b).
We observed a 45% loss of CCAP neuron somata after foxo
overexpression using membrane-associated mCD8::GFP as the
cellular marker (ccap.FOXO, mCD8::GFP), and most of the
remaining cells expressed GFP but not bursicon (supplementary
material Fig. S2). Thus, foxo overexpression resulted in the loss
of most bursicon neurons.
Less severe phenotypes were produced by foxo overexpression
with a second driver, bursicon-Gal4, although the level of GFP
expression was significantly higher than the expression with
ccap-Gal4 (supplementary material Fig. S3), and a later
experiment involving manipulation of the insulin receptor (see
below and supplementary material Fig. S4B,D) also showed no
difference in the efficacy of these two drivers. In pharate adults,
78% of the CCAP/bursicon neurons with foxo overexpression
driven by bursicon-Gal4 remained (supplementary material Fig.
S3), albeit with smaller somata and reduced branching in the
peripheral axon arbor. In addition, the pharate adult somata
displayed a linear arrangement (supplementary material Fig.
S3A) reminiscent of the larval stages (Fig. 1B). We speculate
that differences between the responses of these neurons to foxo
overexpression driven by ccap-Gal4 versus bursicon-Gal4 are
due either to cell–cell interactions (there are fewer cells in the
bursicon-Gal4 pattern), the timing of transgene expression
mediated by these two drivers, insertion position effects, or
differences in genetic backgrounds of these strains.
We then asked whether foxo overexpression disrupted the
earlier development of the CCAP/bursicon neurons (Fig. 1B–G).
We conducted anti-bursicon immunostaining on wandering 3rd
instar stage larvae, which had just initiated metamorphosis. All
CCAP/bursicon cell somata were present. Moreover, there were
no statistically significant changes in soma area (Fig. 1E), bouton
number at the larval neuromuscular junctions (NMJs) (Fig. 1F),
or area covered by each NMJ (Fig. 1G). Therefore, foxo
overexpression specifically inhibited growth of the CCAP/
bursicon neurons during metamorphosis.
During metamorphic remodeling of the CCAP/bursicon
neurons, pruning of larval neurites peaks ,12 hours after
puparium formation (APF) and continues until ,30 hours APF.
Peak outgrowth of adult neurites occurs at 36–54 hours APF, and
outgrowth is largely completed at ,60 hours APF (Zhao et al.,
2008). To determine whether pruning and/or outgrowth were
disrupted by foxo overexpression, we examined anti-bursicon
immunostaining of the CCAP/bursicon neurons at key remodeling
stages. There were no changes observed at 0 hours APF, near the
onset of metamorphosis. However, at 24 hours APF, when pruning
of larval neurites is largely complete (Zhao et al., 2008), we
observed comparable pruning in foxo-overexpressing cells
(ccap.FOXO) and controls (ccap.+) (supplementary material
Fig. S5). At 48 hours APF, when pruning in control cells is
complete and adult neurite outgrowth is well underway (Zhao et
al., 2008), foxo overexpressing cells displayed reduced soma sizes
(supplementary material Fig. S5) and a much smaller and less
branched peripheral axon arbor (data not shown). Therefore, foxo
overexpression spared neurite pruning, but the growth (or
maintenance) of adult-specific neurites was largely blocked, and
many neurons subsequently disappeared altogether or ceased to
express bursicon and ccap-Gal4. Because foxo overexpression
under the bursicon-Gal4 driver and all other IIS manipulations
with the ccap-Gal4 driver (below) did not result in substantial cell
loss, we did not determine whether the loss in ccap.FOXO
animals was due to possible neurotoxic functions of FOXO (Kanao
et al., 2010; Siegrist et al., 2010).
InR regulated metamorphic growth of the CCAP/bursicon
neurons
The IIS pathway negatively regulates FOXO. Specifically, Akt, a
key downstream component of the pathway, phosphorylates
FOXO, blocking its nuclear translocation and thus its
transcriptional regulatory functions (Puig et al., 2003).
Therefore, we tested whether co-overexpression of foxo and
other genes that positively regulate the IIS pathway (InR and
PI3K) restored normal development and function of the CCAP/
bursicon neurons. For cellular analysis, we focused on the
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abdominal CCAP/bursicon neurons, which contain all of the
efferent cells. When either InR or PI3K was overexpressed with
foxo, all adult progeny had fully expanded wings, and the
morphology of the CCAP/bursicon neurons was normal
(supplementary material Fig. S6, and data not shown). These
results confirmed that ectopic expression of InR and PI3K
inhibited FOXO in the CCAP/bursicon neurons. However, these
co-overexpression experiments did not address whether native
IIS directly regulated this remodeling process. To address that
question, we changed IIS levels through cell-targeted down-
regulation and upregulation of InR function and examined the
effects of altered IIS on the CCAP/bursicon neurons at the
pharate adult stage (Fig. 2). Downregulation of InR by expression
of a dominant negative mutant of InR (InRK1409A, hereafter referred
to as InRDN) (Wu et al., 2005; Tweedie et al., 2009) in the CCAP/
bursicon neurons reduced the soma area to 30–52% of normal
(Fig. 2C,E; supplementary material Fig. S4) and the peripheral
axon arbor area to 38% of normal (Fig. 2C9,F). The number of
peripheral axon branches was also reduced to 60% of normal
(Fig. 2C9,G). RNA interference to InR (InRRNAi) (Shim et al.,
2012) produced a similar reduction in the peripheral axon branch
number (Fig. 2D9,G), but any effects on soma area and peripheral
axon arbor were more modest (Fig. 2D,D9,E,F). Overexpression of
InR or expression of a constitutively active mutant of InR
(InRR418P, hereafter referred to as InRact) (Wu et al., 2005;
Tweedie et al., 2009) led to a 208% increase in soma area
(Fig. 2B,E). In addition, the area covered by the peripheral axon
arbor was increased to 189% of controls (Fig. 2B9,F), and the
number of branches in the axon arbor was increased to 140% of
normal (Fig. 2B9,G). These results showed that CCAP/bursicon
neuron soma and axon growth and axon branching during
metamorphosis are strongly dependent on InR activity.
Since the major impacts of foxo overexpression in the CCAP/
bursicon neurons were observed during metamorphosis (and not
Fig. 1. Overexpression of foxo disrupted pharate adult CCAP/bursicon neuron morphology. (A) Cell-targeted expression of foxo in the CCAP/bursicon
neurons (A9) caused the loss of most adult-specific neurites and disappearance (or reduced immunostaining) of many cell bodies at the P14 pharate adult stage.
Cells were labeled by anti-bursicon immunostaining, and the control genotype (ccap.+: ccap-Gal4/+) is shown in panel A. (B,C) In wandering third instar (w3rd)
larvae, the arrangement of CCAP/bursicon somata in the CNS, and the morphology of central neurites (B9) and the peripheral axon arbor (C9), were largely
normal. (D–G) Quantification (with Student’s t-tests) of cellular properties for the experiments shown in panels A–C. Overexpression of foxo significantly
reduced CCAP/bursicon cell number in P14 pharate adults (D) (P,0.0001), but there was no change in larval soma size (E) (P.0.05), larval NMJ bouton number
(F) (P50.35), or NMJ size (G) (P.0.05). Arrows, selected NMJ-like endings on muscles 12 and 13; arrowheads, efferents that terminate within abdominal nerves. ns,
not significant. Scale bars: 100 mm (A,B), 50 mm (C).
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in larvae), we wondered whether altered InR function would also
affect growth of these neurons in a stage-dependent manner. To
test this hypothesis, we conducted anti-bursicon immunostaining
on wandering 3rd instar stage larvae expressing InRDN or InRact in
the CCAP/bursicon neurons. The gross morphology of the larval
CCAP/bursicon neurons was essentially unchanged following
InRDN or InRact expression (Fig. 3).
We also examined the effects of InR manipulations on larval
CCAP/bursicon neuron somata and NMJs. In the abdominal
ganglia, there are eight pairs of abdominal CCAP/bursicon
neurons on each side of the CNS. Within each ‘a/b’ neuron pair,
the ‘a’ neuron has a higher level of bursicon expression than ‘b’
(Zhao et al., 2008). We measured the soma size of A1a (the ‘a’
cell in abdominal ganglion 1), A4a, and A7a, and NMJ bouton
number in segment 4. Interestingly, InRDN did not alter soma size
(Fig. 3B9,D) or larval NMJ bouton number (Fig. 3B0,E). We
obtained similar results with cell-targeted expression of InRRNAi
with Dcr-2 in the CCAP/bursicon neurons (supplementary
Fig. 2. InR regulated metamorphic growth of CCAP/bursicon cell somata and peripheral axon arbor. (A–D) Cell-targeted expression of InRact in the CCAP/
bursicon neurons increased soma size (B) and extent of the peripheral axon arbor (B9) (anti-bursicon immunostaining, stage P14 pharate adults). In contrast,
expression of InRDN and InRRNAi produced smaller somata (C,D) and reduced the peripheral arbor (C9,D9). (E–G) The CCAP/bursicon somata size (E), area covered by
the peripheral axon arbor (F), and number of axonal branches (G) were dependent on InR activity. One or more copies of each transgene were present in
each genotype as indicated below the histograms: CCAP 5 ccap-Gal4; dicer-2 5 UAS-dicer-2; InRact 5 UAS-InRact; InRDN 5 UAS-InRDN; InRRNAi 5 UAS-InRRNAi.
One-way ANOVAs and Tukey–Kramer post-hoc tests were performed on soma size (P,0.001), peripheral arbor area (P,0.001), and peripheral arbor branch number
(P,0.001). Scale bars: 100 mm (A–D), 200 mm (A9–D9).
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material Fig. S7). These results indicate that IIS plays a minor
role in soma and synapse growth of the CCAP/bursicon neurons
during larval development. However, we did observe a
significant increase in soma size with InRact expression in the
cells in more anterior segments (Fig. 3C9,D). Thus, IIS pathway
components are present and functional to some degree in larval
CCAP/bursicon neurons, even if signaling through the pathway is
not normally active until metamorphosis.
We next tested whether additional components of the IIS
pathway regulate the metamorphic growth of the CCAP/bursicon
somata and peripheral axon arbor. First, we looked at the effects of
PI3K, Akt, and Phosphatase and tensin homolog (PTEN), all of
which are key upstream components of the IIS pathway (Wu and
Brown, 2006). The kinases PI3K and Akt are positive regulators of
the IIS pathway, whereas PTEN reduces IIS by inhibiting PI3K
signaling. Increased IIS, through cell-targeted expression of PI3K,
PI3Kact, or PTENRNAi, stimulated metamorphic growth of the cell
bodies and peripheral axon arbor (Fig. 4). Increased levels of wild-
type AKT (which may or may not lead to an increase in the amount
of activated enzyme) produced a significant increase in peripheral
arbor area, but we did not observe a significant increase in soma
size. In contrast to the growth promoting effects of increases in IIS,
decreases in IIS through RNAi to PI3K and Akt, suppressed neurite
branching and growth of the CCAP/bursicon neuron somata
(Fig. 4). These actions of PI3K, Akt, and PTEN in the CCAP/
bursicon neurons further confirmed the role of insulin signaling in
regulating the outgrowth of these neurons during metamorphosis.
FOXO and TSC/TOR regulated metamorphic outgrowth of the
CCAP/bursicon neurons
The IIS pathway regulates cellular growth through two prominent
downstream targets of AKT, FOXO and Tuberous Sclerosis
Complex (TSC)/Target of Rapamycin (TOR) (Ju¨nger et al., 2003;
Oldham and Hafen, 2003). Therefore, we asked whether FOXO
and TSC/TOR both contributed to growth of CCAP/bursicon
neurons during metamorphosis (Fig. 5). Given that foxo
overexpression produced a strong phenotype (Fig. 1), we first
examined the effects of foxo loss-of-function. Following CCAP/
bursicon cell-targeted foxo RNAi, 98% of the adults displayed
unexpanded wings (UEW), and the rest had partially expanded
wings (PEW) (n554). In addition, soma size was increased
(Fig. 5G,I), although the size of the peripheral axon arbor was
unchanged (Fig. 5L). These results suggest that the FOXO arm of
the IIS pathway is involved in the regulation of CCAP/bursicon
soma growth during metamorphic remodeling, whereas other
downstream IIS targets regulate outgrowth and branching of the
CCAP/bursicon peripheral axon arbor. However, we cannot
exclude the possibility that the RNAi to FOXO may have simply
produced a weak FOXO loss-of-function phenotype.
We next examined whether TSC/TOR mediated the effects of
IIS on axon growth and branching during metamorphosis.
Activation of IIS inhibits TSC1/TSC2, a heterodimer that
negatively regulates Rheb, an activator of the TOR complex
(Saucedo et al., 2003; Wullschleger et al., 2006). TOR promotes
growth through either phosphorylation of ribosomal protein
kinase p-70-S6 (S6K) to increase protein synthesis, or inhibition
of 4EBP to enhance translation (Jaeschke et al., 2002; Garami
et al., 2003; Stocker et al., 2003). Activation of TOR through
CCAP/bursicon-targeted expression of UAS-Rheb completely
blocked adult wing expansion (n5100), and it increased
soma size and expanded the peripheral axon arbor in pharate
adults (Fig. 5B,B9). Similarly, RNAi to TSC1 resulted in flies
with 36% UEW and 64% expanded wings (n514) (the
wing expansion phenotype for RNAi to TSC2 was not tested).
We also observed a significant increase in soma size and
peripheral axon arbor following RNAi to TSC1 and TSC2
(Fig. 5D,D9,E,E9,J,M).
Conversely, manipulations that reduced IIS led to decreased
CCAP/bursicon neuron cell growth, although they also disrupted
wing expansion. RNAi to S6K produced flies with 34% UEW,
11% PEW, and 55% expanded wings (n544), with a decrease in
soma size and axon arborization (Fig. 5F,F9,I,L). These results
reveal an important role of the TSC/TOR arm of the IIS pathway
in stimulating metamorphic soma growth and axon outgrowth of
the CCAP/bursicon neurons.
Fig. 3. Larval growth of the CCAP/bursicon neurons was insensitive to loss
of InR. (A–C) Cell-targeted expression of InRDN and InRact in the CCAP/
bursicon neurons had little effect on the larval peripheral arbor (B,C),
central projection pattern (B9,C9), or neuromuscular junctions (NMJ) (B0,C0)
(anti-bursicon immunostaining on w3rd larvae). The arrows in panel A show
selected NMJs, and the insets in panels A9, B9 and C9 show the A1a, A4a, and
A7a somata (from anterior to posterior). (D,E) Quantification of CCAP/
bursicon cell soma size for A1a, A4a, and A7a (D) and normalized bouton
number in abdominal segment 4 (E) for the genotypes in panels A–C. InRact
significantly affected the soma sizes of A1a, A4a, and A7a. In contrast, InRDN
had no effect on soma size (P.0.05). Both InRDN and InRact had no effect on
bouton number (E). One-way ANOVAs and Tukey–Kramer post-hoc tests were
performed on soma size of A1a (P,0.0001), A4a (P,0.0001), and A7a
(P,0.05), and normalized bouton number (P.0.05,). Scale bars: 200 mm
(A–C), 100 mm (A9–C9), 20 mm (A0–C0).
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IIS regulated growth of the Tv neurons during metamorphosis
We next asked whether IIS plays a broader role in regulating
the metamorphic remodeling of other cell types. To address
this question, we first studied another class of neuroendocrine
cells, the Tv neurons, for which there are excellent cell
markers (e.g. anti-RFamide antibodies) and in which neuronal
remodeling during metamorphosis has been well characterized
(Brown et al., 2006). We targeted expression of UAS-foxo,
UAS-InRact, and UAS-InRDN to the Tv neurons and conducted
anti-RFamide immunostaining (Benveniste et al., 1998) on
pharate adult animals. Similar to the effects in the CCAP/
bursicon neurons (Fig. 2B), expression of InRact led to a 28%
Fig. 4. Akt, PI3K, and PTEN regulated metamorphic growth of CCAP/bursicon neurons. (A–G) Cell-targeted expression of Akt, PI3Kact, and PTENRNAi with
Dcr-2 in the CCAP/bursicon neurons increased soma size (B,C,G) and extent of the peripheral axon arbor (B9,C9,G9) (anti-bursicon immunostaining, stage P14
pharate adults). In contrast, expression of AktRNAi and PI3KRNAi with Dcr-2 produced smaller somata (E,F) and reduced the peripheral arbor (E9,F9). Controls
had the ccap-Gal4 driver alone (A) or ccap-Gal4 with only UAS-Dcr-2 (D). Each element used in the representative images in panels A–G was heterozygous.
Scale bars: 50 mm (A–G), 200 mm (A9–G9). (H–L) The CCAP/bursicon soma size (H–J) and peripheral axon arbor area (K,L) were dependent on the activity of
Akt, PI3K and PTEN. Each element used here was heterozygous unless marked with the symbol D, in which case the allele was homozygous. One-way
ANOVAs and Tukey–Kramer post-hoc tests were performed on soma size (H) (P,0.0001), (I) (P,0.001), and (J) (P,0.001). Due to unequal variances, we used
Kruskal–Wallis Multiple-Comparison Z-Value Tests with Bonferroni correction for statistical analysis of the peripheral arbor area in panels K (P,0.05) and L
(P,0.05). Means labeled with different letters are significantly different (P,0.05).
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increase in Tv neuron soma size and a 36% increase in the area
covered by the adult peripheral axon arbor (supplementary
material Fig. S8). In contrast, cell-targeted expression of InRDN
in the Tv neurons significantly reduced soma size to 81% of
normal, although there was no significant difference in the area
covered by the axon arbor (supplementary material Fig. S8).
The latter result may have underreported the effects of IIS on
Tv neuron axon branching and outgrowth, since the arbor has a
highly variable and branched architecture that is largely
constrained on the surface of the CNS. Nevertheless, it is
clear that changes in IIS led to changes in soma growth and
neurite outgrowth, although the effects were modest in
Fig. 5. FOXO and Tor regulated metamorphic growth of CCAP/bursicon neurons. (A–E) Both ccap-Gal4 driven expression of Rheb and RNAi for TSC1
and TSC2 (TSC1RNAi or TSC2RNAi with Dcr-2) increased the soma size (B,D,E) and the area covered by the peripheral axon arbor (B9,D9,E9). Panels A and C show
ccap-Gal4 driver-only controls and UAS-Dcr-2, ccap-Gal4 controls, respectively. In contrast, expression of S6KRNAi with Dcr-2 decreased soma size (F) and the
peripheral axon arbor (F9). Expression of FOXORNAi with Dcr-2 increased soma size (G), but not the peripheral axon arbor (G9). Cells were labeled by anti-bursicon
immunostaining at P14 pharate adult stage. Each element used in the experiments was heterozygous. Scale bars: 20 mm (A–G), 200 mm (A9–G9).
(H–M) Quantification of soma cross-sectional area (H–J) and peripheral axon arbor area (K–M) for CCAP/bursicon cells of the phenotypes shown in panels A–G.
Student’s t-tests were performed on the measurements shown in panels H (P,0.0001) and K (P50.0005). One-way ANOVAs with Tukey–Kramer
post-hoc tests were performed on soma size measurements shown in panels I (P,0.0001) and J (P,0.001) and peripheral axon arbor measurements shown in panels
L (P,0.001) and M (P,0.01). Means labeled with different letters are significantly different.
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comparison to the changes seen in the CCAP/bursicon neurons
(Fig. 2).
IIS regulated the organizational growth, but not maintenance
growth, of many peptidergic neurons
The effects of IIS on organizational growth of two groups of
neurons (CCAP/bursicon and Tv), suggests that IIS may regulate
the growth of many neurons during metamorphosis. To test this
hypothesis, we manipulated InR activity under the control of 386-
Gal4, a pan-peptidergic cell driver (Taghert et al., 2001). It is
difficult to separate and quantify changes in the neurites of single
neurons within such a broad neuronal pattern, and the effects of
IIS on soma size generally paralleled the ones on neurites in the
CCAP/bursicon and Tv neurons (e.g. Fig. 2; supplementary
material Fig. S8). Therefore, we measured soma size as a proxy
for the effects of InR on growth of diverse peptidergic neurons in
the 386-Gal4 pattern. Based on soma morphologies and
locations, we selected five groups of neurons that were easily
distinguished at the wandering 3rd instar larval stage (groups a to
e) and five groups of neurons that were identifiable at the pharate
adult stage (groups f to j) (Fig. 6A,B). For example, the larval
group c neurons had large, round somata located along the dorsal
midline in the ventral nerve cord (Fig. 6A,C), while the pharate
adult group h neurons, which are the insulin-producing cells
(IPCs; data not shown), had large, triangular somata located in
the medial protocerebrum of the brain (Fig. 6B,C). For each
group, we measured the cross-sectional area of cells (visualized
as two-dimensional confocal projections) labeled with the
CD8::GFP marker. In larvae, four of five cell types displayed
no change in soma size in response to InRact or InRDN
(Fig. 6C,D). In contrast, all five groups of pharate adult neurons
displayed marked changes in soma size (Fig. 6C,E). In general,
the growth of most larval neurons appeared refractory to changes
in IIS, whereas most neurons were highly responsive during
metamorphosis. These results suggest that the stage-dependent
regulation of CCAP/bursicon growth by IIS is representative of
many different classes of peptidergic neurons.
Putative local source of IIS for regulation of metamorphic
growth of the CCAP/bursicon neurons
Drosophila insulin-like peptides are encoded by eight genes,
dilp1–8 (Brogiolo et al., 2001; Colombani et al., 2012; Garelli
et al., 2012), which differ in their spatial and temporal expression
patterns. To determine which DILP(s) regulate metamorphic
growth of the CCAP/bursicon neurons, we tested three of the
known or putative sources of circulating DILP hormones: the
brain IPCs, the fat body, and the VNC IPCs (Fig. 7). The brain
IPCs are seven pairs of cells in each brain hemisphere that
synthesize DILP2, 3 and 5 and secrete these hormones into the
hemolymph to regulate glucose homeostasis and growth
(Brogiolo et al., 2001; Ikeya et al., 2002). We ablated the brain
IPCs by expressing the cell death genes, reaper (rpr) and hid
(Schetelig et al., 2011), under the control of the dilp2 promoter
(Rulifson et al., 2002). In this cross, only female progeny
contained the UAS-rpr and UAS-hid transgenes. The male
progeny were normal. In females, the developmental time from
Fig. 6. IIS affected the soma area of most neurons in pharate
adults, but not in larvae. (A,B) Pan-peptidergic expression
pattern of 386-Gal4,UAS-CD8::GFP at the wandering 3rd stage
(A) and the pharate adult stage (B). We analyzed soma sizes
(cross-sectional areas) for five larval groups of neurons labeled
by a to e (A) and five pharate adult groups of neurons labeled by
f to j (B). (C) Higher magnification views of selected neurons
groups (c,e,h,i) expressing InRact, InRDN, or just the 386-Gal4
driver. Groups e and i are the mushroom body Kenyon cells.
Groups d and h are the brain insulin-producing cells. (D,E) Soma
sizes for the larval (D) and pharate adult (E) groups of neurons
indicated in panels A and B following InRact or InRDN
expression. Scale bars: 100 mm. One way ANOVA; Tukey–
Kramer post-hoc tests were performed on soma size (P,0.0001)
and peripheral axon arbor (P,0.0001). n55 for all three
genotypes.
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egg to adult was extended from 12 to 22 days at 25 C˚, and adult
body size was substantially reduced (data not shown), consistent
with earlier findings (Rulifson et al., 2002). Nevertheless, females
displayed normal metamorphic growth of the CCAP/bursicon
neurons (Fig. 7A,D), indicating that the brain IPCs were not
necessary for this growth. We next tested DILP6, which is highly
expressed in the fat body after the late 3rd instar and secreted into
the hemolymph to regulate growth during metamorphosis
(Okamoto et al., 2009; Slaidina et al., 2009). We altered the
level of DILP6 by expression of UAS-dilp6 or UAS-dilp6RNAi with
UAS-Dcr-2 under the control of a fat body-specific driver, cg-
Gal4. Neither of these dilp6 manipulations had any effect on the
CCAP/bursicon neurons (Fig. 7C,F), even though both of these
genotypes alter post-feeding growth regulation (Slaidina et al.,
2009). Finally, we examined the role of DILP7 in the putatively
neuroendocrine dMP2 neurons, which are located in the posterior
of the ventral nerve cord (Miguel-Aliaga et al., 2008; Yang et al.,
2008). Targeted expression of dilp7RNAi with Dcr-2 in the dMP2
neurons had no effect on the CCAP/bursicon somata or axon arbor
(Fig. 7B,E), although the dilp7RNAi RNAi animals displayed a
marked reduction in DILP7 peptide (supplementary material Fig.
S9). Although we cannot exclude the possibility of compensatory
DILP expression (see Discussion) or residual DILP signaling in the
above genotypes, our results indicate that the metamorphic growth
of the CCAP/bursicon neurons is not regulated by DILP2, 3, and 5
from the brain IPCs, DILP6 from the fat body, or DILP7 from the
dMP2 neurons. These findings suggest that a local source of
secreted insulin may regulate metamorphic CCAP/bursicon
neuron growth.
Discussion
Stage-dependent effects of IIS on neuronal development
It is well established that IIS is crucial for regulating cell growth
and division in response to nutritional conditions in Drosophila
(Hietakangas and Cohen, 2009). However, most studies have
focused on growth of the body or individual organs, and
comparatively little is known about the roles of IIS during
neuronal development, particularly in later developmental stages.
Drosophila InR transcripts are ubiquitously expressed throughout
embryogenesis, but are concentrated in the nervous system after
mid-embryogenesis and remain at high levels there through the
adult stage (Garofalo and Rosen, 1988). This suggests that IIS
plays important roles in the post-embryonic nervous system.
Recently, analysis of Drosophila motorneurons, mushroom body
neurons, and IPCs has revealed important roles of PI3K and Rheb
in synapse growth or axon branching (Knox et al., 2007; Howlett
et al., 2008; Acebes et al., 2011; Zhao and Campos, 2012). These
studies revealed some growth regulatory functions of IIS in the
CNS, but they have not explored whether the control of neuronal
growth by IIS is temporally regulated.
Fig. 7. Elimination of circulating DILP sources did not
affect metamorphic growth of the CCAP/bursicon
neurons. (A–C) Confocal images of the CCAP/bursicon
neuron somata and axon arbor following the ablation of
three sources of circulating DILPs. Ablation of the brain
IPCs was achieved through cell-targeted expression of
UAS-rpr, UAS-hid driven by dilp2-Gal4 (A). To
downregulate DILP7, we targeted dilp7RNAi to the VNC
dMP2 neurons with Odd-Gal4 driver (B). Changes in the
level of DILP6 in the fat body were achieved with the
expression of UAS-dilp6RNAi or UAS-dilp6 under the
control of the fat body-specific driver, cg-Gal4 (C).
(D–F) Quantification of CCAP/bursicon cell soma size and
peripheral axon arbor area for the genotypes in panels A–
C. Student’s t-tests and one-way ANOVA test were
performed on soma size and peripheral axon arbor,
respectively; none of the differences were statistically
significant. Scale bars: 20 mm (CNS), 200 mm (peripheral
arbor).
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Here, we have shown that IIS strongly stimulates
organizational growth of neurons during metamorphosis,
whereas the effects of IIS on larval neurons are comparatively
modest (Fig. 6). Recently, another group reported similar results
in mushroom body neurons, in which the TOR pathway strongly
promoted axon outgrowth of c-neurons after metamorphic
pruning (Yaniv et al., 2012). Expression of FOXO or reduction
of InR function had no significant effect on larval growth of the
CCAP/bursicon neurons (Figs 1, 3; supplementary material Fig.
S7), or on the soma size of many other larval neurons (Fig. 6).
Thus, while IIS has been shown to regulate motorneuron synapse
expansion in larvae (Knox et al., 2007; Howlett et al., 2008), our
findings indicate that IIS may not play a major role in regulating
structural growth in many larval neurons. This is consistent with
a recent report that concluded that the Drosophila larval CNS is
insensitive to changes in IIS (Cheng et al., 2011).
When we used InRact to activate IIS without ligand, we saw a
modest but significant increase in the soma size of the more
anterior CCAP/bursicon neurons during larval development
(Fig. 3D). This result indicates that the IIS pathway is present
and functional in these larval neurons, but the ligand for InR is
either absent or inactive. During metamorphosis, unlike in larvae,
downregulation of IIS by altering the level of InR or downstream
components of the pathway significantly reduced CCAP/bursicon
neuron growth (Figs 2, 4, 5). Thus, our results suggest that IIS is
strongly upregulated during metamorphosis to support post-
embryonic, organizational growth of diverse peptidergic neurons,
and this activation may at least in part be due to the presence of
as yet unidentified InR ligands during metamorphosis.
We attempted to identify this proposed InR ligand source by
eliminating, in turn, most of the known sources of systemic
DILPs (Fig. 7). None of these manipulations had any effect on
metamorphic growth of the CCAP/bursicon neurons. These
results are consistent with three possible mechanisms. First, there
may be a compensatory IIS response to loss of some dilp genes.
For example, a compensatory increase in fat body DILP
expression has been observed in response to ablation of brain
dilp genes (Gro¨nke et al., 2010). Second, the growth may be
regulated by another systemic hormone (e.g. DILP8) that was not
tested, or by residual DILP peptides in the RNAi knockdown
animals. Third, a local insulin source may be responsible for
stimulating metamorphic outgrowth of the CCAP/bursicon
neurons. Consistent with this view, a recent report showed that
DILPs secreted from glial cells were sufficient to reactivate
neuroblasts during nutrient restriction without affecting body
growth, while overexpression of seven dilp genes (dilp1–7) in the
IPCs had no effect on neuroblast reactivation under the same
conditions (Sousa-Nunes et al., 2011). It seems likely that glia or
other local DILP sources play an important role in regulating
metamorphic neuron growth, but further experiments will be
needed to test this model.
Wing expansion defects after changes in IIS in the bursicon
neurons
When we manipulated IIS in the CCAP/bursicon neurons, we
observed changes in cell body size (and sometimes shape) and in
the extent of branching in the peripheral axon arbor (Fig. 2).
Although we focused our analysis of neurite growth on the
peripheral axons, which are easily resolved in fillet preparations,
we also observed corresponding changes in the size and
complexity of the central CCAP/bursicon neuron arbor (data
not shown). These IIS manipulations (both upregulation or
downregulation) resulted in the above structural changes as well
as wing expansion defects, suggesting that the normal
connectivity of the CCAP/bursicon neurons was required for
proper functioning of this cellular network. This model is
consistent with the observation of two subsets of morphologically
distinct bursicon-expressing neurons (the BSEG and BAG
neurons), which are activated sequentially to control central
and peripheral aspects of wing expansion (Peabody et al., 2008).
The BSEG neurons project widely within the CNS to trigger wing
expansion behavior as well as secretion of bursicon by the BAG
neurons (Peabody et al., 2008). In turn, the BAG neurons send
axons into the periphery to secrete bursicon into the hemolymph
to control the process of tanning in the external cuticle.
Therefore, manipulation of IIS within these neurons, and the
changes in morphology that result, may disrupt the wiring and
function of this network. However, because we cannot rule out
the possibility that these IIS manipulations also altered neuronal
excitability, synaptic transmission, or neuropeptide secretion
(Zhao et al., 2008), we relied on measurements of cellular
properties (and not wing expansion rates) when assessing the
relative effects of different IIS manipulations on cell growth.
The roles of IIS on age- and context-dependent neuronal
regenerative ability
Our results indicate that IIS is critical for organizational growth,
which occurs during insect metamorphosis but is also seen during
neuronal regeneration in other systems. However, the
regenerative ability of many neurons is age-dependent and
context-dependent (Selzer, 2003; Park et al., 2010); immature
neurons possess a more robust regenerative capacity, while the
regenerative potential of many mature neurons is largely reduced.
In particular, the adult vertebrate CNS displays very limited
regeneration, in marked contrast to the regeneration abilities
displayed by the peripheral nervous system (Ferguson and Son,
2011). Recent studies in mice suggest that age-dependent
inactivation of mTOR contributes to the reduced regenerative
capacity of adult corticospinal neurons, and activation of mTOR
activity through PTEN deletion promoted robust growth of
corticospinal tract axons in injured adult mice (Liu et al., 2010).
Our genetic experiments demonstrate a requirement for activity
of TOR, as well as several other IIS pathway components both
upstream and downstream of TOR, in controlling organizational
growth of many peptidergic neurons. This suggests that under
certain conditions, the activation of IIS may be a crucial
component of the conversion of mature neurons to a more
embryonic-like state, in which reorganizational growth either
after injury or as a function of developmental stage is possible.
Given the strong evolutionary conservation of these systems and
the powerful genetic tools available to identify novel regulatory
interactions in Drosophila, studies on the control of
organizational growth in this species hold great promise for
revealing factors that are crucial for CNS regeneration.
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Fig. S1. The CCAP/bursicon cells grow but maintain a largely constant
gross morphology during larval development. (A–C) CCAP/bursicon
neurons from embryonic stage 17 (A), the second larval instar (B), and the
wandering 3rd larval instar (C). (D) Quantification of soma size for CCAP/
bursicon cells of the genotypes shown in panels A–C. From embryonic stage 17
to the wandering 3rd instar larval stage, the soma size (cross-sectional area) of
the CCAP/bursicon neurons was increased over 2.5-fold. Bars labeled with
different letters are significantly different (P,0.0001, one way ANOVA;
Tukey–Kramer post-hoc test). Scale bars: 20 mm (A), 50 mm (B), 100 mm (C).
Fig. S2. Overexpression of foxo caused loss of
CCAP- and bursicon-expressing neurons at the
pharate adult stage. (A–F) CCAP-Gal4-driven
co-expression of UAS-mCD8::GFP and UAS-foxo
led to loss of neurons in stage P14 pharate adults,
coupled with a significant reduction in soma and
central neurite growth in the remaining neurons
(D–F) (cyan, anti-GFP immunostaining; magenta,
anti-bursicon immunostaining). Most remaining
neurons expressed GFP but not bursicon. The
control genotype (A–C) was CCAP-Gal4, UAS-
mCD8::GFP. Scale bar: 50 mm. (G) Counts of
CCAP neuron somata (GFP, black bars) and
bursicon neuron somata (anti-bursicon, gray bars)
for the genotypes in panels A–F (P,0.0001,
Student’s t-tests).
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Fig. S3. Expression of foxo or InRact
driven by burs-Gal4 altered
metamorphic growth of the CCAP/
bursicon cells. (A) bursicon-Gal4-
driven co-expression of UAS-
mCD8::GFP and UAS-foxo caused a
significant reduction in soma and
peripheral arbor growth and the number
of visible somata (middle panels) at the
pharate adult stage. In contrast,
expression of InRact significantly
increased soma size and the area
covered by the peripheral axon arbor
(lower panels). There was substantial
overlap of the CD8::GFP (cyan) and
anti-bursicon immunostaining (magenta)
signals, and strong CD8::GFP
expression persisted in the somata,
suggesting that the reduction of
peripheral axon arbor area with foxo
overexpression was not due to the loss
of cell markers. (B) The expression level
of CD8::GFP driven by bursicon-Gal4
was higher than the one driven by ccap-
Gal4. (C–E) Quantification of GFP
fluorescence intensity (C), soma area
(D, black bars), soma number (D, gray
bars), and peripheral arbor area (E) of
the CCAP/bursicon cells shown in
genotypes in panels A and B. Means
labeled with different letters were
significantly different. A Student’s t-test
was performed on GFP intensity
(P,0.001). One-way ANOVAs and
Tukey–Kramer post-hoc tests were
performed on soma size (P,0.001),
soma number (P,0.001), and peripheral
arbor area (P,0.001). Scale bars:
20 mm (A, CNS), 200 mm (A, peripheral
arbor), 50 mm (B).
Fig. S4. CCAP-Gal4 and Burs-Gal4 displayed
equivalent efficacy when driving InRDN in the
CCAP/bursicon neurons. (A–D) Expression UAS-
InRDN driven by CCAP-Gal4 (A,B) or Burs-Gal4
(C,D) significantly reduced soma size (B,D) in stage
P14 pharate adults (anti-bursicon immunostaining).
(A) CCAP-Gal4 driver-only controls. (C) Burs-Gal4
driver-only controls. Scale bar: 50 mm. (E) InRDN
expressed under the control of the CCAP-Gal4 and
Burs-Gal4 drivers had similar effects on soma size of
the CCAP/bursicon neurons (P,0.0001, Student’s
t-tests).
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Fig. S5. Overexpression of foxo disrupted metamorphic outgrowth of the
CCAP/bursicon cells. Anti-bursicon immunostaining of the ventral nerve cord
at 0, 24 and 48 hours after puparium formation (APF). In contrast to the
controls (A, with only the ccap-Gal4 driver), CCAP/bursicon cell-targeted
expression of foxo (B) disrupted soma growth (solid arrows) and outgrowth of
adult-specific neurites (solid arrowheads). A similar extent of pruning of the
larval neurites was observed at the 24 hour time point in the two genotypes.
Feathered arrows, lateral longitudinal tracks; feathered arrowheads, midline
arbor. Scale bar: 100 mm.
Fig. S6. InR inhibited the effects of FOXO in the CCAP/bursicon cells.
Cell-targeted expression of InR in the CCAP/bursicon neurons completely
rescued the cell loss and cell growth phenotypes induced by foxo
overexpression. (A,A9) ccap-Gal4 driver-only controls. (B,B9) UAS-InR-only
controls. (C,C9) ccap-Gal4; UAS-foxo. (D,D9) ccap-Gal4; UAS-InR. (E,E9)
ccap-Gal4; UAS-InR, UAS-foxo. Scale bars: 50 mm (A–E), 200 mm (A9–E9).
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Fig. S7. InRRNAi did not reduce soma or synapse
growth in larval CCAP/bursicon cells. (A,B,A9,B9) Cell-
targeted expression of InRRNAi with Dcr-2 in the CCAP/
bursicon neurons had no effect on the general morphology
of the CCAP/bursicon neuron somata and CNS projections
(A,A9), peripheral axon projections (B,B9), or
neuromuscular junction (NMJ)-like endings (anti-bursicon
immunostaining on w3rd larvae). (A,B) UAS-Dcr-2,
CCAP-Gal4 controls. (A9,B9) UAS-Dcr-2, CCAP-Gal4/
UAS-InRRNAi. Scale bars: 100 mm (A,A9), 200 mm (B,B9).
(C–E) InRRNAi had no significant effect on soma area
(C) (P.0.05, Student’s t-test), bouton number
(D) (P.0.05, Student’s t-test), or NMJ bouton area
(E) (P.0.05, Student’s t-test).
Fig. S8. Moderate effects of IIS on the metamorphic growth of Tv neurons.
(A–C) Cell-targeted expression of InRact or InRDN in the Tv neurons changed
the soma size (B,C) and the area covered by the peripheral axon arbor
(B9,C9) (anti-bursicon immunostaining, stage P14 pharate adults). (A,A9) fmrf-
Gal4 driver-only controls. Scale bars: 100 mm. (D,E) Altered InR activity
significantly influenced the soma size of Tv neurons (D) and the peripheral
axonal arbor area (E). One-way ANOVA; Tukey–Kramer post-hoc tests were
performed on soma size (P,0.0001) and peripheral axon arbor (P,0.01).
Means labeled with different letters are significantly different.
Fig. S9. Reduced levels of DILP7 peptide in the dMP2 neurons of
Odd.dilp7RNAi, dicer-2 animals. (A,B) Stage P14 pharate adults expressing
UAS-dilp7RNAi with UAS-dicer2 under the control of Odd-Gal4 displayed
reduced levels of DILP7 peptide (B) compared to UAS-dilp7RNAi, UAS-dicer2-
only controls (A) (anti-DILP7 immunostaining, stage P14 pharate adults). Scale
bar: 25 mm.
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